09 December 2020>: Database Analysis
Identification of a 6-Gene Signature Associated with Resistance to Tyrosine Kinase Inhibitors: Prognosis for Clear Cell Renal Cell Carcinoma
Qinke Li ABCE , Wenbo Yang CD , Maoqing Lu DF , Ronggui Zhang AG*DOI: 10.12659/MSM.927078
Med Sci Monit 2020; 26:e927078
Figure 3 Stratified analysis of 6 differentially expressed genes (6-DEGs) risk scores associated with various clinicopathological parameters in patients with clear cell renal cell carcinoma (ccRCC). Patients were divided into subgroups according to age (<60 vs. ≥60), sex (female vs. male), tumor grade (I+II vs. III+IV), current survival status (alive vs. dead), clinical stage (I+II vs. III+IV), tumor stage (T1+T2 vs. T3+T4), as well as the status of distant metastasis (M0 vs. M1) and lymph node metastasis stage (N0 vs. N1); *** P<0.001; **** P<0.0001.